Home › Endometriosis › NCT06414083
Histologic Comparison of Ablative Techniques for Endometriosis
Recruiting
Histologic Comparison of Ablative Techniques for Endometriosis - a Randomized Trial
Who can join
Ages 18 and older · Women
Full eligibility criteria
Inclusion Criteria: * Adult women 18 years of age or older * Already planning to undergo scheduled robotic assisted or laparoscopic excision of lesions for pelvic pain symptoms (pelvic pain, dysmenorrhea, dyspareunia, dysuria, dyschezia, ovarian pain) or endometriosis of any kind (endometriosis of any location, or endometrioma) Exclusion Criteria: * Known pregnancy at enrollment or at the time of the excision surgery
About the study
To our knowledge, no other human studies directly compare the effectiveness of the various ablative technologies. We set out to design a study to directly compare ablative energy sources and evaluate their ability to destroy native endometriosis tissue in humans.
What is being tested
- Diathermy (device)
- CO2 Laser (device)
- Argon Beam Coagulator (device)
Sponsor: TriHealth Inc. · Participants: 141 · Started: May 9, 2024
Contact the study team
- Devin Namaky, MD · Phone: 513-862-1888
Official record on ClinicalTrials.gov — NCT06414083
Locations in the U.S.
| Ohio | Good Samaritan Hospital, Cincinnati |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.